Quantamental Technologies’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,748
Closed -$207K 498
2023
Q1
$207K Sell
2,748
-6,347
-70% -$472K 0.11% 334
2022
Q4
$717K Sell
9,095
-15,721
-63% -$1.18M 0.33% 96
2022
Q3
$1.74M Buy
+24,816
New +$1.95M 0.68% 10
2022
Q2
Sell
-10,034
Closed -$761K 433
2022
Q1
$761K Buy
+10,034
New +$795K 0.44% 65
2021
Q4
Sell
-7,516
Closed -$568K 404
2021
Q3
$568K Sell
7,516
-9,552
-56% -$758K 0.38% 91
2021
Q2
$1.39M Buy
17,068
+13,873
+434% +$1.13M 1.23% 2
2021
Q1
$252K Buy
+3,195
New +$250K 0.81% 58
2019
Q3
Sell
-8,028
Closed -$575K 1558
2019
Q2
$575K Buy
+8,028
New +$570K 0.21% 106
2019
Q1
Sell
-2,776
Closed -$165K 1511
2018
Q4
$165K Buy
+2,776
New +$174K 0.1% 377

Other funds holding CL

Quantamental Technologies's CL Position: Q2 2023 in Review

Quantamental Technologies sold out of Colgate-Palmolive (CL) in Q2 2023, closing a stake of 2,748 shares — an estimated $207K sold.

Quantamental Technologies first reported a position in CL in Q4 2018 and held it in 9 quarters. The position peaked at $1.74M in Q3 2022. 1,680 funds tracked by Wall St. Rank hold CL as of Q2 2023.

  • Quantamental Technologies reported no remaining Colgate-Palmolive position as of Q2 2023 after selling out during the quarter.
  • Quantamental Technologies sold 2,748 Colgate-Palmolive shares in Q2 2023, an estimated $207K.
  • Quantamental Technologies first reported a position in Colgate-Palmolive in Q4 2018 and held it in 9 quarters.
  • Quantamental Technologies's Colgate-Palmolive position peaked at $1.74M in Q3 2022.
  • 1,680 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.